Royalty Pharma plc
RPRXUpdated . Prices are snapshots and may be delayed.
Royalty Pharma plc price chart
AI Outlook for Royalty Pharma plc
Bullish posture- Long-term trend+15.5% vs 200-day average
- Medium-term trend+1.4% vs 50-day average
- Averages50-day above 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Royalty Pharma plc performance
About Royalty Pharma plc
Royalty Pharma plc is a pharmaceuticals company based in the United States, listed on NASDAQ since 2020 (ticker RPRX).
The shares trade at a price-to-earnings ratio of 39.9. The dividend yield is 2.96%.
Royalty Pharma plc market data
What is the price of Royalty Pharma plc today?
Royalty Pharma plc (RPRX) is at $60.96, +1.79% on the day.
What is the 52-week range of Royalty Pharma plc?
Over the past year Royalty Pharma plc has traded between $35.23 and $64.38. It is currently 88% of the way up that range.
What is the P/E ratio of Royalty Pharma plc?
Royalty Pharma plc trades at a price-to-earnings ratio of 39.9.
Similar stocks
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.